NCT05910073 (CBSL) is a clinical trial of Lamina curved plate in Oroantral Fistula, sponsored by Hôpital NOVO.

Who is sponsoring NCT05910073?

NCT05910073 is sponsored by Hôpital NOVO.

What drugs are being tested in NCT05910073?

Interventions in NCT05910073: Lamina curved plate.

What condition does NCT05910073 study?

NCT05910073 studies Oroantral Fistula.

Is NCT05910073 still recruiting?

NCT05910073 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT05910073: CBSL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy Assessment of Lamina Curved Plate in Managing Oroantral Communication (OACs)

Completed Last updated 19 September 2024

What this trial tests

trial testing Lamina curved plate in Oroantral Fistula in 33 participants. Completed in 29 June 2023.

Timeline

16 May 2023

Primary endpoint
29 June 2023

29 June 2023

Quick facts

Lead sponsor	Hôpital NOVO
Status	Completed
Study type	OBSERVATIONAL
Enrollment	33
Start date	16 May 2023
Primary completion	29 June 2023
Estimated completion	29 June 2023
Sites	1 location across France

Drugs / interventions tested

Lamina curved plate

Conditions studied

Oroantral Fistula — all drugs for Oroantral Fistula →

Sponsor

Hôpital NOVO — full company profile →

Who can join

18 and older, any sex, with Oroantral Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to assess the success rate, of using a Lamina Curved plate (Osteobiol® Laboratory) in the treatment of persistent OACs over 5mm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Oroantral Fistula

Currently open trials in the same condition.

NCT06066086 — A Hinge Flap to Reinforce Buccal Advancement Flap · NA · recruiting

Other Hôpital NOVO trials

Trials by the same sponsor.

NCT07394478 — Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica · not yet recruiting
NCT07412340 — Disarticulation Septoplasty Versus Classical Way · not yet recruiting
NCT07298070 — Functional and Aesthetic Outcomes Following Lower Lip Reconstruction · not yet recruiting
NCT07257094 — Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Reha · recruiting
NCT07505706 — Patient Journey in Palliative Care Within the NOVO Hospital Group. · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05910073 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hôpital NOVO
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05910073.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing